Our Story

Helga Mikkelsen

Investment Manager - Perth

Helga joined Brandon Capital in 2018.

Before joining Helga was part of the team that developed a novel treatment for respiratory disease at the Telethon Kids Institute in Perth, which subsequently became Respirion Pharmaceuticals.  Previously Helga project managed the development of anti-infective medical devices for CamStent in Cambridge, UK.  Helga undertook postdoctoral training in bacterial genetics at Imperial College London.

Helga is a board observer of OncoRes Medical and Respirion Pharmaceuticals.

Helga has both a Bachelor and Masters of Science in Chemical Engineering and Biotechnology from the Technical University of Denmark and a PhD in Microbiology from the University of Cambridge. She is a Graduate of the Australian Institute of Company Directors.

Brandon Capital is aware of scammers impersonating us - offering jobs and asking for bank details. We do not offer employment or ask for banking details via SMS, websites or phone calls. Do not provide any details and report to the relevant authorities in your location.